The Vaccine: Inside the Race to Conquer the COVID-19 Pandemic | 誠品線上

光速計畫: BioNTech疫苗研發之路

內容簡介

內容簡介 科學家夫妻創立 BioNTech ，​​開發 COVID-19 疫苗！當在中國武漢發現COVID-19時，BioNTech 已部署尖端技術並創造世界上第一個臨床批准的新冠疫苗。2019 年末，新冠病毒開始橫掃全球，每天成千上萬人染疫，救命任務迫在眉睫。研究癌症免疫療法的BioNTech憑藉對 mRNA 技術的信念，在疫情爆發後，以大膽的創意和精確的科學態度，以不到一年的速度，開發出劃時代的BNT疫苗。《光速計畫》刻劃了這時代最重要的醫療里程碑：BioNTech創辦人吳沙忻、圖雷西與團隊的救世意志，新科技疫苗研發的科學進展、生技公司在商場及政治的合作協調，得以讓 BNT 疫苗迅速問世，成為人類打贏這場戰疫的後盾。吳沙忻在（2020 年）1月24日就明白了這場全球大流行的規模。我遠不及他的速度。—— 前任德國總理，梅克爾（Angela Merkel）吳沙忻與圖雷西，是繼居禮夫婦發現放射性後，最被頌揚的科學夫婦。—— 倫敦《泰唔士報》這是一本關於醫學壯舉的傑出報導。—— 《科克斯書評》（Kirkus）本中文書介出自《光速計畫: BioNTech疫苗研發之路》遠見天下文化出版股份有限公司出版Winners of the Paul Ehrlich PrizeThe dramatic story of the married scientists who founded BioNTech and developed the first vaccine against COVID-19.Nobody thought it was possible. In mid-January 2020, Ugur Sahin told Özlem Türeci, his wife and decades-long research partner, that a vaccine against what would soon be known as COVID-19 could be developed and safely injected into the arms of millions before the end of the year. His confidence was built upon almost thirty years of research. While working to revolutionize the way that cancerous tumors are treated, the couple had explored a volatile and overlooked molecule called messenger RNA; they believed it could be harnessed to redirect the immune system's forces against any number of diseases. As the founders of BioNTech, they faced widespread skepticism from the scientific community at first; but by the time Sars-Cov-2 was discovered in Wuhan, China, BioNTech was prepared to deploy cutting edge technology and create the world’s first clinically approved inoculation for the coronavirus.The Vaccine draws back the curtain on one of the most important medical breakthroughs of our age; it will reveal how Doctors Sahin and Türeci were able to develop twenty vaccine candidates within weeks, convince Big Pharma to support their ambitious project, navigate political interference from the Trump administration and the European Union, and provide more than three billion doses of the Pfizer BioNTech vaccine to countries around the world in record time.Written by Joe Miller—the Financial Times’ Frankfurt correspondent who covered BioNTech’s COVID-19 project in real time—with contributions from Sahin and Türeci, as well as interviews with more than sixty scientists, politicians, public health officials, and BioNTech staff, the book covers key events throughout the extraordinary year, as well as exploring the scientific, economic, and personal background of each medical innovation. Crafted to be both completely accessible to the average reader and filled with details that will fascinate seasoned microbiologists, The Vaccine explains the science behind the breakthrough, at a time when public confidence in vaccine safety and efficacy is crucial to bringing an end to this pandemic."

作者介紹

作者介紹 Joe MillerJoe Miller is the Frankfurt correspondent for Financial Times. He previously reported for BBC News in London, New York, Delhi, and Berlin.Dr. Özlem TüreciDr. Özlem Türeci and Dr. Ugur Sahin are the husband-and-wife team that cofounded BioNTech, developers of the world’s first COVID-19 vaccine. The children of Turkish migrant workers in Germany, they trained as medical doctors and earned doctorates in molecular biology and immunotherapy. They have done extensive work in the field of translational oncology and written hundreds of scientific papers and patents.Dr. Ugur SahinDr. Ugur Sahin and Dr. Özlem Türeci are the husband-and-wife team that cofounded BioNTech, developers of the world’s first COVID-19 vaccine. The children of Turkish migrant workers in Germany, they trained as medical doctors and earned doctorates in molecular biology and immunotherapy. They have done extensive work in the field of translational oncology and written hundreds of scientific papers and patents.

商品規格

活動

• 5/9前 全站滿$3,000享92折
• 5/9前 全站滿$5,000享9折
• 5/9前 全站滿$1,500享93折